Cholinesterase inhibitors in the “real world” setting: rivastigmine versus donepezil tolerability and effectiveness study

Journal Title: Archives of Medical Science - Year 2006, Vol 2, Issue 3

Abstract

Introduction: Comparative tolerability and effectiveness of donepezil and rivastigmine in clinical practice using a “real life” sample of patients diagnosed as having mild to moderate Alzheimer’s disease and treated in the memory clinic setting have not been properly studied to date. Material and methods: A retrospective, case records analysis of all patients (N=183) who had been prescribed either drug over the period of 3 years (1998-2000) and were seen for at least 6 months afterwards. Main outcome estimates were: for tolerability the likelihood to achieve recommended doses for both drugs and side effects profiles, for effectiveness clinical global impression of change (CGI) rating at 6 months after dose titration finished. Results: Numerically, more subjects on rivastigmine than on donepezil dropped out early due to side effects (14.6% vs 11.9%). A maximum approved dose (10 mg for donepezil and 12 mg for rivastigmine) has been achieved by significantly more patients on donepezil than on rivastigmine (p

Authors and Affiliations

Tomasz Sobow, Iwona Kloszewska

Keywords

Related Articles

Absence of superficial palmar arch with associated anomaly of ulnar artery and nerve: a case report with clinical implications

Normally the ulnar artery and the ulnar nerve pass superficial to the flexor retinaculum of the wrist. In the present study, we describe an ulnar artery and ulnar nerve which passed deep to the flexor retinaculum and an...

The cardiologists\' dream may come true – vascular therapy

Recently there has been a great evolution of new diagnostic and therapeutic methods of cardiovascular diseases. However, they still remain the most common death cause in the Western countries. Despite the fact that new m...

Interleukin-6 serum concentration in patients with impaired growth hormone secretion

There is a growing number of studies which have revealed that the growth hormone (GH) plays a role in regulation of systemic inflammatory response. Interleukin-6 (IL-6) is a well established pro-inflammatory, proangiogen...

Download PDF file
  • EP ID EP91184
  • DOI -
  • Views 188
  • Downloads 0

How To Cite

Tomasz Sobow, Iwona Kloszewska (2006). Cholinesterase inhibitors in the “real world” setting: rivastigmine versus donepezil tolerability and effectiveness study. Archives of Medical Science, 2(3), 194-198. https://europub.co.uk/articles/-A-91184